Recent developments in the treatment of blastic plasmacytoid dendritic cell neoplasm

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a clinically aggressive hematologic malignancy derived from precursors of dendritic cells and involves most frequently the skin, bone marrow and lymph nodes. Diagnosis depends upon identification of specific tumor markers including CD4, CD56 an...

Descripción completa

Detalles Bibliográficos
Autores principales: Economides, Minas P., Konopleva, Marina, Pemmaraju, Naveen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759709/
https://www.ncbi.nlm.nih.gov/pubmed/31579499
http://dx.doi.org/10.1177/2040620719874733

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759709/
https://www.ncbi.nlm.nih.gov/pubmed/31579499
http://dx.doi.org/10.1177/2040620719874733

Ejemplares similares